Natural History Museum, United Kingdom Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2006
NCT00659997
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Natural History Museum, London, UK

Active Ingredients

Drugs in Phase 4 Trials (2)

albendazole (Albenza) (3 trials)

levamisole (ergamisol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ascariasis (Phase 4)

Ascaridiasis (Phase 4)

Filariasis (Phase 4)

Helminthiasis (Phase 4)

Trichuriasis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2